{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:24:50Z","timestamp":1765545890472},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1758-5996-6-7","type":"journal-article","created":{"date-parts":[[2014,1,22]],"date-time":"2014-01-22T18:22:57Z","timestamp":1390414977000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Vitamin D concentrations in familial combined hyperlipidemia: effects of lipid lowering treatment"],"prefix":"10.1186","volume":"6","author":[{"given":"Inka","family":"Mi\u00f1ambres","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Luis","family":"S\u00e1nchez-Quesada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"S\u00e1nchez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"de Leiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,22]]},"reference":[{"issue":"5","key":"280_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1365-2265.2011.04147.x","volume":"75","author":"S Pilz","year":"2011","unstructured":"Pilz S, Tomaschitz A, Marz W, Drechsler C, Ritz E, Zittermann A, Cavalier E, Pieber TR, Lappe JM, Grant WB, Holick MF, Dekker JM: Vitamin D, cardiovascular disease and mortality. Clin Endocrinol (Oxf). 2011, 75 (5): 575-584. 10.1111\/j.1365-2265.2011.04147.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"280_CR2","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1161\/CIRCOUTCOMES.112.967604","volume":"5","author":"L Wang","year":"2012","unstructured":"Wang L, Song Y, Manson JE, Pilz S, M\u00e4rz W, Micha\u00eblsson K, Lundqvist A, Jassal SK, Barrett-Connor E, Zhang C, Eaton CB, May HT, Anderson JL, Sesso HD: Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: ameta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes. 2012, 5 (6): 819-829. 10.1161\/CIRCOUTCOMES.112.967604.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"280_CR3","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1210\/jc.2012-2368","volume":"98","author":"M Karakas","year":"2013","unstructured":"Karakas M, Thorand B, Zierer A, Huth C, Meisinger C, Roden M, Rottbauer W, Peters A, Koenig W, Herder C: Low levels of serum 25-hydroxyvitamin D are associated with increased risk of myocardial infarction, especially in women: results from the MONICA\/KORA Augsburg case-cohort study. J Clin Endocrinol Metab. 2013, 98 (1): 272-280. 10.1210\/jc.2012-2368.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"280_CR4","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1161\/HYPERTENSIONAHA.108.117630","volume":"52","author":"JP Forman","year":"2008","unstructured":"Forman JP, Curhan GC, Taylor EN: Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension. 2008, 52 (5): 828-832. 10.1161\/HYPERTENSIONAHA.108.117630.","journal-title":"Hypertension"},{"issue":"3","key":"280_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10654-013-9790-2","volume":"28","author":"SK Kunutsor","year":"2013","unstructured":"Kunutsor SK, Apekey TA, Steur M: Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants. Eur J Epidemiol. 2013, 28 (3): 205-221. 10.1007\/s10654-013-9790-2.","journal-title":"Eur J Epidemiol"},{"issue":"9","key":"280_CR6","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/ejcn.2011.118","volume":"65","author":"J Mitri","year":"2011","unstructured":"Mitri J, Muraru MD, Pittas AG: Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr. 2011, 65 (9): 1005-1015. 10.1038\/ejcn.2011.118.","journal-title":"Eur J Clin Nutr"},{"issue":"2","key":"280_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1373\/clinchem.2012.193003","volume":"59","author":"S Afzal","year":"2013","unstructured":"Afzal S, Bojesen SE, Nordestgaard BG: Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysis. Clin Chem. 2013, 59 (2): 381-391. 10.1373\/clinchem.2012.193003.","journal-title":"Clin Chem"},{"issue":"8","key":"280_CR8","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1007\/s00125-012-2544-y","volume":"55","author":"NG Forouhi","year":"2012","unstructured":"Forouhi NG, Ye Z, Rickard AP, Khaw KT, Luben R, Langenberg C, Wareham NJ: Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies. Diabetologia. 2012, 55 (8): 2173-2182. 10.1007\/s00125-012-2544-y.","journal-title":"Diabetologia"},{"issue":"4","key":"280_CR9","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.plipres.2011.05.001","volume":"50","author":"R Jorde","year":"2011","unstructured":"Jorde R, Grimnes G: Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog Lipid Res. 2011, 50 (4): 303-312. 10.1016\/j.plipres.2011.05.001.","journal-title":"Prog Lipid Res"},{"issue":"3","key":"280_CR10","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1381\/0960892053576758","volume":"15","author":"J Ybarra","year":"2005","unstructured":"Ybarra J, Sanchez-Hernandez J, Gich I, De Leiva A, Rius X, Rodr\u00edguez-Espinosa J, P\u00e9rez A: Unchanged hypovitaminosis D and secondary hyperparathyroidism in morbid obesity after bariatric surgery. Obes Surg. 2005, 15 (3): 330-335. 10.1381\/0960892053576758.","journal-title":"Obes Surg"},{"issue":"5","key":"280_CR11","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.2337\/diacare.28.5.1228","volume":"28","author":"ES Ford","year":"2005","unstructured":"Ford ES, Ajani UA, McGuire LC, Liu S: Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care. 2005, 28 (5): 1228-1230. 10.2337\/diacare.28.5.1228.","journal-title":"Diabetes Care"},{"key":"280_CR12","doi-asserted-by":"publisher","first-page":"691803","DOI":"10.5402\/2012\/691803","volume":"2012","author":"I Minambres","year":"2012","unstructured":"Minambres I, Sanchez-Hernandez J, Sanchez-Quesada JL, Rodr\u00edguez J, de Leiva A, P\u00e9rez A: The association of hypovitaminosis d with the metabolic syndrome is independent of the degree of obesity. ISRN Endocrinol. 2012, 2012: 691803-","journal-title":"ISRN Endocrinol"},{"issue":"5","key":"280_CR13","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1089\/met.2012.0020","volume":"10","author":"KC Maki","year":"2012","unstructured":"Maki KC, Fulgoni VL, Keast DR, Rains TM, Park KM, Rubin MR: Vitamin D intake and status are associated with lower prevalence of metabolic syndrome in U.S. adults: National Health and Nutrition Examination Surveys 2003\u20132006. Metab Syndr Relat Disord. 2012, 10 (5): 363-372. 10.1089\/met.2012.0020.","journal-title":"Metab Syndr Relat Disord"},{"issue":"6","key":"280_CR14","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1530\/EJE-09-0496","volume":"161","author":"DM Lee","year":"2009","unstructured":"Lee DM, Rutter MK, O\u2019Neill TW, Boonen S, Vanderschueren D, Bouillon R, Bartfai G, Casanueva FF, Finn JD, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean ME, Pendleton N, Punab M, Silman AJ, Wu FC: European Male Ageing Study Group: Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men. Eur J Endocrinol. 2009, 161 (6): 947-954. 10.1530\/EJE-09-0496.","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"280_CR15","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1210\/jc.2010-2202","volume":"96","author":"E Grethen","year":"2011","unstructured":"Grethen E, McClintock R, Gupta CE, Jones R, Cacucci BM, Diaz D, Fulford AD, Perkins SM, Considine RV, Peacock M: Vitamin D and hyperparathyroidism in obesity. J Clin Endocrinol Metab. 2011, 96 (5): 1320-1326. 10.1210\/jc.2010-2202.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"280_CR16","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/sj.ijo.0800413","volume":"21","author":"JF Ascaso","year":"1997","unstructured":"Ascaso JF, Sales J, Merchante A, Real J, Lorente R, Martinez-Valls J, Carmena R: Influence of obesity on plasma lipoproteins, glycaemia and insulinaemia in patients with familial combined hyperlipidaemia. Int J Obes Relat Metab Disord. 1997, 21 (5): 360-366. 10.1038\/sj.ijo.0800413.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"10","key":"280_CR17","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1161\/01.ATV.18.10.1548","volume":"18","author":"L Karjalainen","year":"1998","unstructured":"Karjalainen L, Pihlajamaki J, Karhapaa P, Laakso M: Impaired insulin-stimulated glucose oxidation and free fatty acid suppression in patients with familial combined hyperlipidemia: a precursor defect for dyslipidemia?. Arterioscler Thromb Vasc Biol. 1998, 18 (10): 1548-1553. 10.1161\/01.ATV.18.10.1548.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"280_CR18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1161\/01.ATV.13.3.427","volume":"13","author":"JE Hokanson","year":"1993","unstructured":"Hokanson JE, Austin MA, Zambon A, Brunzell JD: Plasma triglyceride and LDL heterogeneity in familial combined hyperlipidemia. Arterioscler Thromb. 1993, 13 (3): 427-434. 10.1161\/01.ATV.13.3.427.","journal-title":"Arterioscler Thromb"},{"issue":"2","key":"280_CR19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-2275(20)38008-1","volume":"24","author":"JD Brunzell","year":"1983","unstructured":"Brunzell JD, Albers JJ, Chait A, Grundy SM, Groszek E, McDonald GB: Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J Lipid Res. 1983, 24 (2): 147-155.","journal-title":"J Lipid Res"},{"issue":"19","key":"280_CR20","first-page":"730","volume":"113","author":"JA Gomez-Gerique","year":"1999","unstructured":"Gomez-Gerique JA, Gutierrez-Fuentes JA, Montoya MT, Porres A, Rueda A, Avellaneda A, Rubio MA: Lipid profile of the Spanish population: the DRECE (diet and risk of cardiovascular disease in Spain) study. DRECE study group. Med Clin (Barc). 1999, 113 (19): 730-735.","journal-title":"Med Clin (Barc)"},{"issue":"6","key":"280_CR21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RJ, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem. 1972, 18 (6): 499-502.","journal-title":"Clin Chem"},{"issue":"25","key":"280_CR22","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"National Cholesterol Education Program (NCEP)","year":"2002","unstructured":"National Cholesterol Education Program (NCEP): Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Circulation. 2002, 106 (25): 3143-3421.","journal-title":"Circulation"},{"issue":"5","key":"280_CR23","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0022-2275(20)30111-5","volume":"43","author":"JL Sanchez-Quesada","year":"2002","unstructured":"Sanchez-Quesada JL, Benitez S, Otal C, Franco M, Blanco-Vaca F, Ord\u00f3\u00f1ez-Llanos J: Density distribution of electronegative LDL in normolipemic and hyperlipemic subjects. J Lipid Res. 2002, 43 (5): 699-705.","journal-title":"J Lipid Res"},{"issue":"8","key":"280_CR24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1157\/13126339","volume":"208","author":"A Goday","year":"2008","unstructured":"Goday A, Gabriel R, Ascaso JF, Franch J, Ortega R, Mart\u00ednez O, Lenores N, DESIRE study: Cardiovascular risk in subjects with high probability of metabolic syndrome and insulin resistance. DESIRE study. Rev Clin Esp. 2008, 208 (8): 377-385. 10.1157\/13126339.","journal-title":"Rev Clin Esp"},{"issue":"4","key":"280_CR25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ijsu.2013.02.007","volume":"11","author":"D Benaiges","year":"2013","unstructured":"Benaiges D, Flores Le-Roux JA, Pedro-Botet J, Chillar\u00f3n JJ, Renard M, Parri A, Ramon JM, Pera M, Goday A: Sleeve gastrectomy and Roux-en-Y gastric bypass are equally effective in correcting insulin resistance. Int J Surg. 2013, 11 (4): 309-313. 10.1016\/j.ijsu.2013.02.007.","journal-title":"Int J Surg"},{"issue":"2","key":"280_CR26","doi-asserted-by":"crossref","first-page":"507S","DOI":"10.1093\/ajcn\/88.2.507S","volume":"88","author":"BW Hollis","year":"2008","unstructured":"Hollis BW: Measuring 25-hydroxyvitamin D in a clinical environment: challenges and needs. Am J Clin Nutr. 2008, 88 (2): 507S-510S.","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"280_CR27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/jn\/135.2.317","volume":"135","author":"BW Hollis","year":"2005","unstructured":"Hollis BW: Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr. 2005, 135 (2): 317-322.","journal-title":"J Nutr"},{"issue":"40","key":"280_CR28","first-page":"1254","volume":"128","author":"H Wilczek","year":"1989","unstructured":"Wilczek H, Sobra J, Justova V, Ceska R, J\u016fzov\u00e1 Z, Proch\u00e1zkov\u00e1 R, Kvasilov\u00e1 M, Pacovsk\u00fd V: Iatropathogenic effect of Mevacor on vitamin D metabolism. Cas Lek Cesk. 1989, 128 (40): 1254-1256.","journal-title":"Cas Lek Cesk"},{"issue":"15","key":"280_CR29","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1001\/archinte.168.15.1629","volume":"168","author":"ML Melamed","year":"2008","unstructured":"Melamed ML, Michos ED, Post W, Astor B: 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008, 168 (15): 1629-1637. 10.1001\/archinte.168.15.1629.","journal-title":"Arch Intern Med"},{"issue":"7","key":"280_CR30","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.2337\/dc09-0209","volume":"32","author":"L Lu","year":"2009","unstructured":"Lu L, Yu Z, Pan A, Hu FB, Franco OH, Li H, Li X, Yang X, Chen Y, Lin X: Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care. 2009, 32 (7): 1278-1283. 10.2337\/dc09-0209.","journal-title":"Diabetes Care"},{"issue":"3","key":"280_CR31","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1161\/CIRCULATIONAHA.111.077875","volume":"126","author":"MP Ponda","year":"2012","unstructured":"Ponda MP, Huang X, Odeh MA, Breslow JL, Kaufman HW: Vitamin D may not improve lipid levels: a serial clinical laboratory data study. Circulation. 2012, 126 (3): 270-277. 10.1161\/CIRCULATIONAHA.111.077875.","journal-title":"Circulation"},{"key":"280_CR32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/1475-2840-11-149","volume":"11","author":"A Guasch","year":"2012","unstructured":"Guasch A, Bullo M, Rabassa A, Bonada A, Del Castillo D, Sabench F, Salas-Salvad\u00f3 J: Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study. Cardiovasc Diabetol. 2012, 11: 149-10.1186\/1475-2840-11-149.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"280_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00223-006-0024-4","volume":"79","author":"L Rejnmark","year":"2006","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L: Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case\u2013control study. Calcif Tissue Int. 2006, 79 (1): 27-36. 10.1007\/s00223-006-0024-4.","journal-title":"Calcif Tissue Int"},{"issue":"7","key":"280_CR34","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.amjcard.2006.11.036","volume":"99","author":"JL Perez-Castrillon","year":"2007","unstructured":"Perez-Castrillon JL, Vega G, Abad L, Sanz A, Chaves J, Hernandez G, Due\u00f1as A: Effects of Atorvastatin on vitamin D levels in patients with acute ischemic heart disease. Am J Cardiol. 2007, 99 (7): 903-905. 10.1016\/j.amjcard.2006.11.036.","journal-title":"Am J Cardiol"},{"issue":"2","key":"280_CR35","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1755-5922.2010.00141.x","volume":"29","author":"DT Ertugrul","year":"2011","unstructured":"Ertugrul DT, Yavuz B, Cil H, Ata N, Akin KO, Kucukazman M, Yalcin AA, Dal K, Yavuz BB, Tutal E: STATIN-D Study: Comparison of the Influences of Rosuvastatin and Fluvastatin Treatment on the Levels of 25 Hydroxyvitamin D. Cardiovasc Ther. 2011, 29 (2): 146-152. 10.1111\/j.1755-5922.2010.00141.x.","journal-title":"Cardiovasc Ther"},{"issue":"2","key":"280_CR36","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.atherosclerosis.2011.08.009","volume":"219","author":"J Beltowski","year":"2011","unstructured":"Beltowski J, Atanassova P, Chaldakov GN, Jamroz-Wi\u015bniewska A, Kula W, Rusek M: Opposite effects of pravastatin and atorvastatin on insulin sensitivity in the rat: role of vitamin D metabolites. Atherosclerosis. 2011, 219 (2): 526-531. 10.1016\/j.atherosclerosis.2011.08.009.","journal-title":"Atherosclerosis"},{"issue":"4","key":"280_CR37","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10557-009-6182-7","volume":"23","author":"DS Grimes","year":"2009","unstructured":"Grimes DS: Statins and vitamin D : editorial to: \u201cincreased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins?\u201d by Bunyamin Yavuz et al. Cardiovasc Drugs Ther. 2009, 23 (4): 261-262. 10.1007\/s10557-009-6182-7.","journal-title":"Cardiovasc Drugs Ther"},{"key":"280_CR38","doi-asserted-by":"publisher","first-page":"957174","DOI":"10.1155\/2010\/957174","volume":"2010","author":"L Rejnmark","year":"2010","unstructured":"Rejnmark L, Vestergaard P, Heickendorff L, Mosekilde L: Simvastatin does not affect vitamin d status, but low vitamin d levels are associated with dyslipidemia: results from a randomised, controlled trial. Int J Endocrinol. 2010, 2010: 957174-","journal-title":"Int J Endocrinol"},{"issue":"3","key":"280_CR39","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/1074248412470513","volume":"18","author":"EN Liberopoulos","year":"2013","unstructured":"Liberopoulos EN, Makariou SE, Moutzouri E, Kostapanos MS, Challa A, Elisaf M: Effect of Simvastatin\/Ezetimibe 10\/10 mg Versus Simvastatin 40 mg on Serum Vitamin D Levels. J Cardiovasc Pharmacol Ther. 2013, 18 (3): 229-233. 10.1177\/1074248412470513.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"20","key":"280_CR40","first-page":"630","volume":"132","author":"H Wilczek","year":"1993","unstructured":"Wilczek H, Sobra J, Ceska R, Justov\u00e1 V, Proch\u00e1zkov\u00e1 R, Kvasilov\u00e1 M, J\u016fzov\u00e1 Z: Therapy with fibrates and vitamin D metabolism. Cas Lek Cesk. 1993, 132 (20): 630-632.","journal-title":"Cas Lek Cesk"}],"container-title":["Diabetology & Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1758-5996-6-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T02:52:04Z","timestamp":1630551124000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/1758-5996-6-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,22]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["280"],"URL":"https:\/\/doi.org\/10.1186\/1758-5996-6-7","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,22]]},"assertion":[{"value":"2 October 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"7"}}